EBO:NZXEBOS Group Limited Analysis
Data as of 2026-09-08 - not real-time
$2.15
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Ebang International Holdings Inc. trades at $2.15, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has gained 6.6%. With RSI at 50.0 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $1.88 up to resistance at $2.36.
Revenue is growing at 9.5% on a -181.5% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 59.7%, a beta of 1.45 and a maximum drawdown of 68.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Revenue is growing at 9.5% on a -181.5% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 59.7%, a beta of 1.45 and a maximum drawdown of 68.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Ebang International Holdings Inc. Announces Unaudited Financial Results For The First Half Of Fiscal Year 2026. GROVER,...GROVER, N.C., Aug. 14, 2026 GLOBE NEWSWIRE -- Ebang International Holdings Inc. Nasdaq: EBON the 'Company,” 'we,”...Detailed price information for Ebang International Holdings Cl A EBON-Q from The Globe and Mail including charting and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 2.51
- MACD momentum is negative
- 30-day price change of +6.6%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 2.51
- 30-day volatility of 59.7%
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -181.5%
- Negative return on equity of -6.2%
- 30-day volatility of 59.7%
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin-181.47%
ROE-6.16%
ROA-5.39%
Debt/Equity0.51
P/B Ratio0.1
Industry P/E33.3
Technical Analysis
TrendNeutral
RSI50.0
Support$1.88
Resistance$2.36
MA 20$2.16
MA 50$2.09
MA 200$2.51
MACDBearish
VolumeDecreasing
Fear & Greed Index93.36
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta1.45
Volatility59.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.